Why realistic testing prevents innovation failure
Great innovation concepts can still fail in market. Learn how realistic testing in competitive contexts prevents costly failures during development.
The recent shift towards consumerism and patient empowerment is driving companies to reevaluate the role and design of patient support programs. Historically, pharmaceutical manufacturers implemented support programs largely as a way to address patient non-adherence. These programs were often single-based solutions designed to meet mass market needs. Next generation patient support programs will go beyond simple adherence to address holistic disease management through patient-centric service offerings.
These next-generation “beyond the pill” patient programs are still new, and many of the concepts have yet to be widely embraced. However, some pharmaceutical companies have already begun re-evaluating their current set of offerings with the goal of enhancing patient engagement, retaining brand loyalty, and thwarting the switch to biosimilars or other competitive branded products.
In this article published exclusively in WARC, Bill Salokar – our VP Client Solutions – discussed how a recent shift towards consumerism and patient empowerment has encouraged companies to reassess the role and structure of patient support programs.
This paper explores:
Please make sure you're subscribed to WARC to read the entire article or contact Bill Salokar if you don't have an access to WARC.
Be the first to receive the latest market research insights, tips from industry peers and exclusive content to help you influence decision behavior.
Great innovation concepts can still fail in market. Learn how realistic testing in competitive contexts prevents costly failures during development.
SKIM named a gold-level pricing consulting leader in 2025 UK rankings—recognized for client impact, expertise, and innovation.
Discover how Alpro create winning sustainability claims that motivate consumers to purchase by connecting to primary choice drivers.
Prevent costly innovation failures and gain a strategic advantage during uncertain times by understanding audience habits first.